Hospital-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Hospital-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-02-28FDA Approved: AVYCAZ — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for AVYCAZ (ceftazidime-avibactam) from Allergan, Inc., authorizing changes to the approved labeling…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Clinical Impact of a Multiplex Rapid Diagnostic Pneumonia Panel Testing in Critically-ill Patients With Severe Hospital-acquired Pneumonia, Ventilator-associated Pneumonia and Community-acquired Pneumonia With High Risk of Multidrug Resistant Pathogen [NA]
This clinical trial update evaluates the impact of a multiplex rapid diagnostic pneumonia panel in critically ill patients with severe hospi…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneumonia [NA]
A recruiting clinical trial studying long-term changes in host-microbiome interactions and the progression of cardiovascular and respiratory…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults [Phase 4]
Phase 4 trial results evaluate the efficacy and safety of ceftazidime-avibactam (CAZ-AVI) for carbapenem-resistant Gram-negative infections …
-
FDA approval · 2024-10-10FDA Approved: LINEZOLID — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original ANDA for LINEZOLID (linezolid), making a generic linezolid available in the U.S. fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP) [Phase 4]
Phase 4 study assessing the efficacy and safety of Ceftazidime-Avibactam in Chinese patients with hospital-acquired pneumonia, including ven…
-
FDA approval · 2024-08-22FDA Approved: LINEZOLID — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for LINEZOLID (linezolid); the approval finalizes changes to the …
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia [Phase 2]
A Phase 2 trial evaluating presepsin as a biomarker to guide immunotherapy in pneumonia has completed, including community-acquired pneumoni…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. [Phase 3]
Phase 3 study evaluating aztreonam-avibactam ± metronidazole versus meropenem ± colistin for serious Gram-negative infections, including com…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics [Phase 4]
Phase 4 clinical trial evaluating rapid diagnostic-guided use of ceftazidime-avibactam for bloodstream infections and ventilator-associated …
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients [Phase 4]
Phase 4 trial updates the efficacy of intravenous Amboxol hydrochloride as an adjunct therapy for severe pneumonia in critically ill patient…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016) [Phase 3]
Phase 3 trial MK-7655A-016 comparing Imipenem/Cilastatin/Relebactam to Piperacillin/Tazobactam in hospital-acquired and ventilator-associate…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: "Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype. [Phase 2, Phase 3]
Clinical trial updates for baricitinib in hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype across Pha…
-
FDA approval · 2022-10-31FDA Approved: LINEZOLID — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' LINEZOLID generic under an Original Abbreviated New Drug Application (ANDA 211813). The approval covers…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia [Phase 1]
Phase 1 single-dose pharmacokinetic study of ceftazidime-avibactam in hospitalized children receiving systemic antibiotics for suspected or …
-
FDA approval · 2022-02-17FDA Approved: LINEZOLID — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Linezolid submitted by Hospira, Inc. under NDA206473.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study [Phase 2]
A Phase 2 randomized trial evaluating human recombinant interferon gamma-1b for preventing hospital-acquired pneumonia in critically ill pat…
-
FDA approval · 2021-07-29FDA Approved: ZOSYN IN GALAXY CONTAINERS — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to allow Zosyn (piperacillin/tazobactam) to be supplied in Galaxy containers, by Wyeth Pharmaceutica…
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Effect of Angulus on Patient-elevation Compliance [NA]
Clinical trial completed investigating Angulus and its impact on patient-elevation compliance in ventilated patients; results posted in 2021…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens [Phase 3]
Phase 3 trial evaluating Cefiderocol (S-649266) versus best available therapy for severe infections due to carbapenem-resistant Gram-negativ…
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens [Phase 3]
Phase 3 clinical trial of Cefiderocol for healthcare-associated pneumonia and hospital-acquired pneumonia has completed with results posted …
-
CLINICAL_TRIALS research · 2020-11-13Clinical Trial Update: The Applicability of Different Scoring Systems and Use of Steroids in the Treatment of Hospital Acquired Pneumonia [Phase 4]
A Phase 4 trial update exploring scoring systems and steroid use in hospital-acquired pneumonia.
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia [Phase 3]
Phase 3 pediatric trial update for ceftobiprole in community-acquired and hospital-acquired pneumonia; study completed with results posted.
-
FDA approval · 2020-02-20FDA Approved: VIBATIV — Supplemental Application (Cumberland Pharmaceuticals Inc.)
FDA approved a supplemental application for VIBATIV (telavancin hydrochloride) from Cumberland Pharmaceuticals Inc. The approval indicates t…
-
FDA approval · 2019-07-16FDA Approved: RECARBRIO — Original Application (Merck Sharp & Dohme LLC)
FDA approved RECARBRIO (imipenem/cilastatin/relebactam) under NDA 212819 from Merck Sharp & Dohme LLC, marking the original approval of this…